Direct isolation of donor-derived CMV-specific T-cells and their adoptive transfer for treatment or prophylaxis of CMV infection following allogeneic HSCT

被引:0
|
作者
Lowdell, M. W. [1 ]
Thomson, K. [1 ]
Armoogum, J. [1 ]
Pang, K. [1 ]
Samuel, E. [1 ]
Desborough, M. [1 ]
Mackinnon, S. [1 ]
机构
[1] Royal Free & UCL Med Sch, London, England
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S54 / S54
页数:1
相关论文
共 50 条
  • [1] Direct isolation and infusion of donor-derived CMV-specific T cells for treatment or prophylaxis of CMV infection following allogeneic transplantation
    Lowdell, M. W.
    Thomson, K.
    Julie, A.
    Pang, K.
    Samuel, E.
    Desborough, M.
    Mackinnon, S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 19 - 19
  • [2] Direct isolation of donor-derived antigen - Specific T cells and their adoptive transfer for treatment or prophylaxis of CMV infection following allogeneic transplantation.
    Thomson, Kirsty
    Julie, Moran
    Pang, Kwok
    Samuel, Ed
    Desborough, Michael
    Lowdell, Mark W.
    Mackinnon, Stephen
    BLOOD, 2006, 108 (11) : 177A - 178A
  • [3] A phase II study of cellular adoptive immunotherapy with donor-derived CMV-specific T-cell clones as prophylaxis for CMV disease in allogeneic HCT recipients
    Boeckh, M.
    Manley, T.
    Greenberg, P.
    Kirby, K.
    Riddell, S.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S2 - S2
  • [4] Adoptive Transfer of CMV-Specific Donor T Cells Following Allogeneic Transplantation Leads to Rapid and Safe Systemic Reconstitution
    Peggs, Karl S.
    Thomson, Kirsty
    Samuel, Edward
    Dyer, Gemma
    Armoogum, Julie
    Pang, Kwok
    Chakraverty, Ronjon
    Mackinnon, Stephen
    Lowdell, Mark W.
    BLOOD, 2009, 114 (22) : 24 - 24
  • [5] Treatment of a patient with severe cytomegalovirus (CMV) infection after haploidentical stem cell transplantation with donor-derived CMV-specific T cells
    Ingels, Joline
    De Smet, Saskia
    Heyns, Kelly
    Lootens, Nele
    Segaert, Jonas
    Taghon, Tom
    Leclercq, Georges
    Vermaelen, Karim
    Willems, Evelyne
    Baudoux, Etienne
    Kerre, Tessa
    Baron, Frederic
    Vandekerckhove, Bart
    ACTA CLINICA BELGICA, 2021, 76 (06) : 482 - 486
  • [6] Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation
    Blyth, Emily
    Clancy, Leighton
    Simms, Renee
    Ma, Chun K. K.
    Burgess, Jane
    Deo, Shivashni
    Byth, Karen
    Dubosq, Ming-Celine
    Shaw, Peter J.
    Micklethwaite, Kenneth P.
    Gottlieb, David J.
    BLOOD, 2013, 121 (18) : 3745 - 3758
  • [7] DEVELOPMENT OF A TREATMENT REGIMEN FOR HUMAN CYTOMEGALOVIRUS (CMV) INFECTION IN BONE-MARROW TRANSPLANTATION RECIPIENTS BY ADOPTIVE TRANSFER OF DONOR-DERIVED CMV-SPECIFIC T-CELL CLONES EXPANDED INVITRO
    GREENBERG, PD
    REUSSER, P
    GOODRICH, JM
    RIDDELL, SR
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1991, 636 : 184 - 195
  • [8] Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation
    Ma, Chao
    Chen, Peng
    Du, Jishan
    Wang, Lu
    Lu, Ning
    Sun, Jiaojun
    Xu, Qilong
    Wang, Yu
    Dou, Liping
    Liu, Dai-Hong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (01)
  • [9] Adoptive Transfer of CMV-Specific TCR-T Cells for the Treatment of CMV Infection after Haploidentical Hematopoietic Stem Cell Transplantation
    Chao, Ma
    Liu Daihong
    Dou, Liping
    BLOOD, 2023, 142
  • [10] CMV-specific donor T cells for the treatment of recurrent CMV infections in transplanted patients
    Tonn, T.
    Grigoleit, G. U.
    Busch, D.
    Germeroth, L.
    Schuly, N.
    Anderl, F.
    Odendahl, M.
    Seifried, E.
    Einsele, H.
    VOX SANGUINIS, 2008, 95 : 203 - 203